Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) active compounds, including selective serotonin reuptake inhibitors (SSRIs) and other neuropsychiatric agents. Its structure supports high affinity binding to certain neurotransmitter receptors, such as 5-HT (serotonin) receptors, making it valuable in drug discovery for depression, anxiety, and other psychiatric disorders.

The compound, featuring a benzothiazole core with a piperidin-4-yl at position 2 and a trifluoromethyl group at position 5, is also explored as a starting material or intermediate in synthesizing new bioactive compounds. Benzothiazole derivatives show potential in antimicrobial and anti-inflammatory applications in some research contexts.

Additionally, it is investigated for anticonvulsant and analgesic effects due to interactions with ion channels and pain pathways. The trifluoromethyl group enhances cell membrane permeability, contributing to the potential development of fast-acting and highly specific drugs.